These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5616439)

  • 1. [Problems of oral contraception with special reference to the development, pharmacodynamics and effectiveness of currently used preparations].
    Richter RH
    Ther Umsch; 1967 Jun; 24(6):218-25. PubMed ID: 5616439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of the structure of steroids on their antiovulatory, antigonadotropic, and progestative activity].
    Jayle MF
    Therapie; 1968; 23(2):201-21. PubMed ID: 5701506
    [No Abstract]   [Full Text] [Related]  

  • 3. [Micro-progestins in oral contraception].
    Bernard I; Levrier M
    Gynecologie; 1978; 29(6):573-80. PubMed ID: 750242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contraception by ovulation inhibitors].
    Döring GK
    Landarzt; 1966 Nov; 42(31):1403-7. PubMed ID: 5979396
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal contraception. Clinical experience, gained up to now and present-day problems].
    Teter J
    Pol Tyg Lek; 1970 Nov; 25(44):1641-3. PubMed ID: 5481409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the progestin-estrogen oral contraceptives on blood serum copper, copper oxidase, magnesium and sulphur concentrations.
    de Jorge FB; Canato C; Medici C; Delascio D
    Matern Infanc (Sao Paulo); 1967; 26(3):261-7. PubMed ID: 5603640
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormonal contraception].
    Kohoutek M; Fabián M; Kohoutek F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(5):691-5. PubMed ID: 5257733
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral contraceptives. Experience of the last 10 years].
    Kuttenn F; Detoeuf M; de Lignières B
    Rev Prat; 1980 Dec; 30(57):4015-6, 4019-20, 4025-6 passim. PubMed ID: 7455551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism in inhibition of ovulation in oral contraception. II. The effect of PMS and HCG observed at laparotomy in patients treated with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone ogether with 17-alpha-ethynyl-oestradiol-3-methylether.
    Starup J; Ostergaard E
    Acta Endocrinol (Copenh); 1966 Jun; 52(2):292-304. PubMed ID: 5952708
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogens, progestins and blood lipids].
    Tikkanen MJ
    Duodecim; 1984; 100(22):1500-3. PubMed ID: 6518995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism in inhibition of ovulation in oral contraception. 3. The excretion of total pituitary gonadotrophins and luteinizing hormone in fertile women during cyclical treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone together with 17-alpha-ethynyl-oestradinol-3-methylether.
    Starup J; Lebech PE
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):188-96. PubMed ID: 6072686
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of oral contraceptives on biochemistry "normal values".
    Wilson LM
    Can J Med Technol; 1973 Dec; 55(6):42-58. PubMed ID: 4764752
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic and vascular consequences of hormonal contraception in non-diabetics].
    Basdevant A; Guy-Grand B
    Journ Annu Diabetol Hotel Dieu; 1983; ():223-37. PubMed ID: 6358613
    [No Abstract]   [Full Text] [Related]  

  • 16. The new progestins.
    Nakajima ST
    West J Med; 1994 Aug; 161(2):163. PubMed ID: 7941537
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary results of comparative trials of oral contraceptives].
    Arnold M; Mall-Haefeli M; Cloeren S; Morf E; Richter RH; Roth F; Stamm H; Wyss H; Weis P
    Gynaecologia; 1966; 162(5):447-52. PubMed ID: 5960452
    [No Abstract]   [Full Text] [Related]  

  • 18. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative review of third-generation progestins.
    Kafrissen ME; Corson SL
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():103-13. PubMed ID: 8260967
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemistry, pharmacology and clinical pharmacology of oral contraceptives.
    Fekete G
    Ther Hung; 1968; 16(1):3-10. PubMed ID: 5646265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.